A high-energy form of ultrasound produces images of liver tumors that are more conspicuous than those from traditional ultrasound, according to results of a clinical study.
A high-energy form of ultrasound produces images of liver tumors that are more conspicuous than those from traditional ultrasound, according to results of a clinical study.
Researchers at Duke University's Pratt School of Engineering found that acoustic radiation force impulse (ARFI) ultrasound may improve on conventional B-mode ultrasound for screening patients at increased risk for liver cancers. It may also guide biopsy procedures and minimally invasive therapies aimed at destroying cancerous tissues found deep in the abdomen.
Results based on evaluation of 12 liver tumors in nine patients were reported in the Jan. 7 issue of Physics in Medicine and Biology. Under the guidance of radiologist Dr. Gregg Trahey, Brian Fahey, Ph.D., and colleagues found that ARFI either improved or produced equivalent boundary definition for suspicious liver mass when compared with B-mode ultrasound.
The mean contrast for suspected hepatocellular carcinomas was 7.5 dB (range: 3.1-11.9) in the ARFI images compared with 2.9 dB (range 1.5-4.2) for B-mode ultrasound. The mean contrast for metastases was 9.3 dB (range: 5.7-13.9) for ARFI compared with 3.1 dB (range: 1.2-5.2) for B-mode ultrasound.
First developed six years ago by Duke biomedical engineers Trahey and Kathy Nightingale, ARFI uses high-energy sound waves to push on tissues like sonic fingers. A tracking beam then captures the movement of the tissue, providing a measure of its elasticity or stiffness.
"To our knowledge, these are the first images of abdominal malignancies in humans that show tissue elasticity," said Trahey, a professor of biomedical engineering, radiology, and medical physics at Duke.
Preliminary findings described in Fahey's Ph.D. thesis led Siemens Medical Systems to pursue a product prototype that will combine traditional ultrasound with ARFI, he said.
In general, primary liver cancers are soft, while those that have spread from other organs are hard. ARFI may be able to tell the difference between hard and soft tumors, Trahey said.
"If borne out in further studies, [that discriminating ability] suggests that ARFI may be useful in guiding treatment decisions," he said.
Traditional ultrasound is now the guidance method of choice in many hospitals for procedures targeting the liver, kidneys, pancreas, and lymph nodes, Trahey said. A significant number of tumors are difficult to see with this method, however, requiring physicians to resort to alternatives such as CT and MRI, which add to the complexity and cost.
Collaborators on the study included Dr. Rendon Nelson, vice chair of radiology at Duke, along with David Bradway, Stephen Hsu and Douglas Dumont, all biomedical engineering graduate students at Pratt.
For more information from the Diagnostic Imaging archives:
Breast ultrasound elastography scores in new studies
MR elastography tops noninvasive staging of liver fibrosis
Exam distinguishes benign from malignant lesions
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.